Journal of Religion and Health

, Volume 5, Issue 3, pp 175–208 | Cite as

Implications of LSD and experimental mysticism

  • Walter N. Pahnke
  • William A. Richards


Experimental Mysticism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abramson, H. A., ed.,The Use of LSD in Psychotherapy. New York, Josiah Macy Jr., Foundation Publications, 1960.Google Scholar
  2. 2.
    Crochet, R., Sandison, R., and Walk, A., eds.,Hallucinogenic Drugs and Their Psychotherapeutic Use. Springfield, Ill., Thomas, 1963.Google Scholar
  3. 3.
    Abramson, H. A., ed.,Proceedings of the Second International Conference on the Use of LSD in Psychotherapy. To be published by Bobbs-Merrill in Fall, 1966.Google Scholar
  4. 4.
    Pahnke, Walter N.,Drugs and Mysticism: An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness. Unpublished Ph.D. thesis. Cambridge, Harvard University, 1963.Google Scholar
  5. 5.
    James, William,The Varieties of Religious Experience. New York, Modern Library, 1902.Google Scholar
  6. 6.
    Stace, Walter T.,Mysticism and Philosophy. Philadelphia and New York, J. B. Lippincott, 1960.Google Scholar
  7. 7.
    See Huxley, Aldous,The Doors of Perception, bound withHeaven and Hell. New York and Evanston, Harper Colophon Books, 1963 (1954), p. 22.Google Scholar
  8. 8.
    James,op. cit. p. 371.Google Scholar
  9. 9.
    See Otto, Rudolf,The Idea of the Holy, tr. by J. W. Harvey. New York, Galaxy Books, 1958 (1932), esp. pp. 12–40.Google Scholar
  10. 10.
    Blofeld, John, “A High Yogic Experience Achieved with Mescaline,”Psychedelic Review, 1966, (No. 7) p. 29.Google Scholar
  11. 11.
    Tillich, Paul,The Courage to Be. New Haven and London, Yale University Press, 1952, p. 185.Google Scholar
  12. 12.
    Ibid. p. 164.Google Scholar
  13. 13.
    Stace,op. cit. pp. 50–51.Google Scholar
  14. 14.
    Spencer, A. M., “Permissive Group Therapy with Lysergic Acid Diethylamide,”The British Journal of Psychiatry, 1963,109, (No. 458) 37.PubMedGoogle Scholar
  15. 15.
    Fernandez-Cerdeno, Arturo,Die Reaktivierung von Erlebnissen aus dem ersten Lebensjahr durch Halluzinogene (Altersregression). Unpublished dissertation. Göttingen, Georg-August University, 1964, p. 18.Google Scholar
  16. 16.
    Ling, Thomas M., Buckman, John, “The Treatment of Frigidity with LSD and Ritalin,”Psychedelic Review, 1964,1, (No. 4) 455.Google Scholar
  17. 17.
    Hoffer, Abraham, “d-Lysergic Acid Diethylamide (LSD): A Review of its Present Status,”Clinical Pharmacology and Therapeutics, 1965,6, (No. 2) 183–255.Google Scholar
  18. 18.
    Blum, Richard and Associates,Utopiates: The Use and Users of LSD-25. New York, Atherton Press, 1964.Google Scholar
  19. 19.
    Pahnke,op. cit..Google Scholar
  20. 20.
    Pahnke, Walter N., Paper presented to the conference on “Religion and Parapsychology,” St. Paul de Vence, France, June 1965. To be published in theInternational Journal of Parapsychology, 1966,8, No. 2. See also, “The Contribution of the Psychology of Religion to the Therapeutic Use of the Psychedelic Substances.” To be published in the proceedings of the Second Conference on the Use of LSD in Psychotherapy, Abramson, H. A., ed. In press, Bobbs-Merrill, 1966.Google Scholar
  21. 21.
    Quoted by LaBarre, Weston,The Peyote Cult. New Haven, Yale University Press, 1938, p. 23.Google Scholar
  22. 22.
    Zaehner, R. C., “The Menace of Mescalin,”Blackfriars, 1954,35 (Nos. 412–413), 310.Google Scholar
  23. 23.
    Zaehner's description of his experience is published in his book,Mysticism: Sacred and Profane, An Inquiry into Some Varieties of Praeternatural Experience. New York, Galaxy Books, 1961, pp. 212–226.Google Scholar
  24. 24.
    See Meduna, L. J.,Carbon Dioxide Therapy. Sprinfield, Ill. Thomas, 1950.Google Scholar
  25. 25.
    Smith, Huston, “Do Drugs Have Religious Import?,” Reprinted from theJournal of Philosophy, 1964,61 (No. 18) 517–530, in Solomon, David, ed.,LSD: The Consciousness-Expanding Drug. New York, G. P. Putnam's Sons, 1964, p. 165.Google Scholar
  26. 26.
    Tillich, Paul,Systematic Theology, vol. III. Chicago, University of Chicago Press, 1963, p. 243.Google Scholar
  27. 27.
    Jaspers, Karl,Der philosophische Glaube angesichts der Offenbarung. Munich, R. Piper & Co. Verlag, 1962. See also Jaspers' dialogue with Heinz Zahrnt,Philosophie und Offenbarungsglaube: Ein Zwiegespräch. Hamburg, Furche-Verlag, 1963.Google Scholar
  28. 28.
    Sandison, R. A., Spencer, A. M., and Whitlaw, J. D. A., “The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness,”Journal of Mental Science, 1954,100, 491–507.PubMedGoogle Scholar
  29. 29.
    Leuner, Hanscarl,Die Experimentelle Psychose. Berlin, Springer Verlag, 1962.Google Scholar
  30. 30.
    Mascher, E., “Psycholytic Therapy: Long Term Statistics and Indications.” Paper presented at the conference of theCollegium Internationale Neuropsychopharmacologicum in Washington, March, 1966.Google Scholar
  31. 31.
    Chwelos, N., Blewett, D. B., Smith, C. M., and Hoffer, A., “Use of LSD-25 in the Treatment of Chronic Alcoholism,”Quarterly Journal of Studies on Alcohol, 1959,20 (No. 3) 577–590.PubMedGoogle Scholar
  32. 32.
    MacLean, J. R., MacDonald, D. C., Byrne, U. P., and Hubbard, A. M., “The Use of LSD-25 in the Treatment of Alcoholism and Other Psychiatric Problems,”Quarterly Journal of Studies on Alcohol, 1961,22, 34–45.PubMedGoogle Scholar
  33. 33.
    Sherwood, J. N., Stolaroff, M. J., and Harmon, W. W., “The Psychedelic Experience—A New Concept in Psychotherapy,”Journal of Neuropsychiatry, 1962,4 (No. 2) pp. 69–80.PubMedGoogle Scholar
  34. 34.
    Unger, Sanford M., “Mescaline, LSD, Psilocybin, and Personality Change: A Review,”Psychiatry: Journal for the Study of Interpersonal Processes 1963,26 (No. 2) 111–125.Google Scholar
  35. 35.
    Unger, Sanford M., “LSD and Psychotherapy: A Bibliography of the English-Language Literature,”Psychedelic Review, 1964,1 (No. 4) pp. 442–449.Google Scholar
  36. 36.
    Kurland, A., Unger S., and Shaffer, I., “Psychedelic Therapy with Alcoholic Patients.” Paper presented at the conference of theCollegium Internationale Neuro-psychopharmacologicum in Washington, March, 1966. See also from the same conference, Savage, C., “An Outline of Psychedelic Therapy.”Google Scholar
  37. 37.
    Leary, Timothy, Metzner, Ralph, Presnell, Madison, Weil, Gunther, Schwitzgebel, Ralph, Kinne, Sara, “A Change Program for Adult Offenders Using Psilocybin,”Psychotherapy, 1965,2 See also Leary, Timothy, and Clark, Walter H., “Religious Implications of Consciousness-Expanding Drugs,”Reliligious Education, 1963, May–June, 251–256.Google Scholar
  38. 38.
    Levine, J., and Ludwig, A., “Hypnodelic Therapy.” Paper presented at the Second International Conference on the Use of LSD in Psychotherapy, Amityville, New York, May 1965. This paper discusses the treatment of drug addicts. The use of this technique in the treatment of alcoholism was described by Ludwig in “An Outline of Hypnodelic Therapy,” presented at the conference of theCollegium Internationale Neuro-psychopharmacologicum in Washington, March, 1966.Google Scholar
  39. 39.
    Kast, Eric, “Pain and LSD-25: A Theory of Attenuation of Anticipation,” in Solomon,LSD: The Consciousness-Expanding Drug, op. cit..Google Scholar
  40. 40.
    Cohen, Sidney, “LSD and the Anguish of Dying,”Harper's Magazine, 1965,231 (No. 1384) 69–72, 77–78.Google Scholar
  41. 41.
    Chwelos,et al., op. cit. p. 589.Google Scholar
  42. 42.
    Prince, R. H., and Savage, Charles, “Mystical States and the Concept of Regression.” Paper presented at the conference of the R. M. Bucke Memorial Society on “Personality Change and Religious Experience,” Montreal, January, 1965.Google Scholar
  43. 43.
    Frosch, W. A., Robbins, Edwin S., Stern, Marvin, “Untoward Reactions to Lysergic Acid Diethylamide (LSD) Resulting in Hospitalization,”New England Journal of Medicine, 1965,273 (No. 23) 1235–1239.PubMedGoogle Scholar
  44. 44.
    Cohen, Sidney, “Lysergic Acid Diethylamide: Side Effects and Complications,”Journal of Nervous and Mental Disease, 1960,130 (No. 1) 30–40.PubMedGoogle Scholar
  45. 45.
    Levine, Jerome, and Ludwig, Arnold M., “The LSD Controversy,”Comprehensive Psychiatry, 1964,5, (No. 5) 314–321.Google Scholar
  46. 46.
    Rosenfeld, Albert, and Farrell, Barry, “The Spread and Perils of LSD,”Life, 1966,60 (No. 12) 28–33.Google Scholar

Copyright information

© Academy of Religion and Mental Health 1966

Authors and Affiliations

  • Walter N. Pahnke
  • William A. Richards

There are no affiliations available

Personalised recommendations